Compare CNTN & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTN | AMTX |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.5M | 134.2M |
| IPO Year | 2021 | 2023 |
| Metric | CNTN | AMTX |
|---|---|---|
| Price | $2.32 | $1.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 575.8K | ★ 668.9K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.10 | 32.98 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $77,194,000.00 |
| Revenue This Year | N/A | $49.77 |
| Revenue Next Year | N/A | $57.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 174.60 |
| 52 Week Low | $1.75 | $1.30 |
| 52 Week High | $5.27 | $3.80 |
| Indicator | CNTN | AMTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.56 | 52.14 |
| Support Level | $2.14 | $1.37 |
| Resistance Level | $2.40 | $1.85 |
| Average True Range (ATR) | 0.16 | 0.10 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 77.43 | 19.11 |
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.